Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Nanoviricides, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 31 | 27 | −4 |
| Shares | 1.25M | 1.23M | −18.5K (−1.5%) |
| Value | $1.47M | $1.42M | −$48.7K (−3.3%) |
New holders (1)
Institutions that held Nanoviricides, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 24,131 | $27.8K | 0.00% |
Sold out (5)
Institutions that held Nanoviricides, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 53,773 | $63.0K |
| Citadel Advisors LLC | 15,205 | $17.8K |
| Tower Research Capital LLC (TRC) | 1,526 | $2.00K |
| Advisory Services Network, LLC | 25 | $29 |
| FMR LLC | 1 | $1 |